| Symbol |
Name |
|
ACTG1
|
actin gamma 1
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ANXA1
|
annexin A1
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
ARFGEF1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
|
|
CLDN1
|
claudin 1
|
|
CLDN3
|
claudin 3
|
|
CLDN4
|
claudin 4
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
DMTN
|
dematin actin binding protein
|
|
DUOX1
|
dual oxidase 1
|
|
DUOX2
|
dual oxidase 2
|
|
EMILIN1
|
elastin microfibril interfacer 1
|
|
EMILIN2
|
elastin microfibril interfacer 2
|
|
ENPP4
|
ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative)
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
FERMT1
|
fermitin family member 1
|
|
FERMT2
|
fermitin family member 2
|
|
FOXC2
|
forkhead box C2
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HTN1
|
histatin 1
|
|
HTN3
|
histatin 3
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
KANK1
|
KN motif and ankyrin repeat domains 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYLK
|
myosin light chain kinase
|
|
OCLN
|
occludin
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PTK2
|
protein tyrosine kinase 2
|
|
REG3A
|
regenerating islet-derived 3 alpha
|
|
REG3G
|
regenerating islet-derived 3 gamma
|
|
RREB1
|
ras responsive element binding protein 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SMOC2
|
SPARC related modular calcium binding 2
|
|
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
|
|
THBS1
|
thrombospondin 1
|
|
TMEM97
|
transmembrane protein 97
|
|
TTF2
|
transcription termination factor, RNA polymerase II
|
|
VEGFB
|
vascular endothelial growth factor B
|
|
VTN
|
vitronectin
|
|
XBP1
|
X-box binding protein 1
|
